Aleix Cases

Patients with multiple myeloma requiring long‐term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

E. Montserrat, R. Torra, J. Bladé, 1995, British journal of haematology.

Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa.

G. Escolar, A. Cases, A. Ordinas, 1990, Blood.

Recombinant human erythropoietin treatment improves platelet function in uremic patients.

G. Escolar, A. Cases, J. Reverter, 1992, Kidney international.

Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.

M. Díaz-Ricart, G. Escolar, M. Carretero, 2000, Kidney international.

[Anemia in chronic kidney disease and its cardiovascular implications].

E. Coll, A. Cases, S. Collado, 2009, Medicina clinica.

Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques.

N. Villamor, G. Escolar, A. Cases, 1994, The Journal of laboratory and clinical medicine.

Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.

F. Calero, P. Barceló, A. Cases, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.

J. López-Pedret, Lluis Revert, Aleix Cases, 1990, Nephron.

Efficacy of a simple dosage scheme to convert from shorter-acting erythropoiesis-stimulating agent to continuous erythropoietin receptor activator in kidney transplantation patients.

A. Sánchez-Escuredo, F. Batista, Aleix Cases, 2015, Transplantation proceedings.